Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ South Ural State Uni...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Уровень информированности врачей Челябинской области о фармакогенетике и фармакогенетическом тестировании

Authors: Barysheva, V. O.; Ketova, G. G.; Kremlev, S. L.; Klimova, E. V.;

Уровень информированности врачей Челябинской области о фармакогенетике и фармакогенетическом тестировании

Abstract

Изучена осведомленность медицинских работников о фармакогенетике, фармакогенетических тестах. Проведен анкетный опрос 1058 докторов медицинских и профилактических учреждений Челябинска и Челябинской области. Серьезным препятствием к внедрению фармакогенетических тестов в практику является недостаточный уровень знаний в области клинической фармакогенетики у врачей и работников сферы здравоохранения, а также существующее мнение о высокой стоимости и низкой доступности фармакогенетического тестирования. Studying of awareness of medical workers about pharmacogenetics, farmakogenetichesky tests was the purpose of our research. There was an alleged questionnaire of 1058 doctors of medical and preventive institutions of Chelyabinsk and Chelyabinsk region. Serious obstacle to introduction of farmakogenetichesky tests in practice is insufficient level of knowledge in the field of clinical pharmacogenetics at doctors and organizers of health care, and also existing opinion on high cost and low availability of farmakogenetichesky testing. Барышева В.О., аспирант кафедры профессиональных болезней и клинической фармакологии, Южно-Уральский государственный медицинский университет (Челябинск), wanna_have_fun@mail.ru. Кетова Г.Г., доктор медицинских наук, профессор кафедры профессиональных болезней и клинической фармакологии, Южно-Уральский государственный медицинский университет (Челябинск), Galina_Ketova@mail.ru. Кремлев С.Л., доктор медицинских наук, профессор кафедры общественное здоровье и здравоохранение факультета послевузовского и дополнительного профессионального образования, Клиника Южно-Уральского государственного медицинского университета (Челябинск), kremlev57@mail.ru. Климова Е.В., кандидат медицинских наук, заместитель главного врача, Клиника Южно-Уральского государственного медицинского университета (Челябинск), Elena_klimova@fromru.com. V.O. Barysheva, South Ural State Medical University, Chelyabinsk, Russian Federation, wanna_have_fun@mail.ru, G.G. Ketova, South Ural State Medical University, Chelyabinsk, Russian Federation, Galina_Ketova@mail.ru, S.L. Kremlev, Clinic of the South Ural State Medical University, Chelyabinsk, Russian Federation, kremlev57@mail.ru, E.V. Klimova, Clinic of the South Ural State Medical University, Chelyabinsk, Russian Federation, Elena_klimova@fromru.com

Country
Russian Federation
Keywords

УДК 614.23(470.55), фармакогенетические тесты, клиническая фармакогенетика, информированность врачей, awareness of physicians, 575 [УДК 615], ГРНТИ 76.75, clinical pharmacogenetics, pharmacogenetic tests

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Green